Ellen Cavaleri

Ellen Cavaleri has 14 years of experience in investor relations, communications and public affairs. Before joining Lyra in 2022, Ellen served as Senior Vice President, Investor Relations and Communications at Kadmon Holdings, Inc., a biopharmaceutical company. At Kadmon, she created and implemented the company’s investor relations strategy and oversaw all external and internal communications. She played an active role in several financing rounds for Kadmon and led communications for the clinical development, U.S. regulatory approval and commercialization of the company’s first therapeutic REZUROCK (belumosudil) as well as the acquisition of Kadmon by Sanofi in November 2021. Previously, she was a senior associate at The Corkery Group, where she supported Gilead Sciences’ communications strategy. Ms. Cavaleri graduated magna cum laude from Vanderbilt University with a B.A. in English. She received her master’s degree in business administration from New York University.